CX Institutional’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.74M | Sell |
59,588
-6,686
| -10% | -$973K | 0.25% | 92 |
|
|
2026
Q1 | $9.57M | Sell |
66,274
-49,403
| -43% | -$7.49M | 0.29% | 76 |
|
|
2025
Q4 | $16.6M | Buy |
115,677
+44,172
| +62% | +$6.51M | 0.49% | 45 |
|
|
2025
Q3 | $11M | Buy |
71,505
+3,595
| +5% | +$561K | 0.33% | 61 |
|
|
2025
Q2 | $10.8M | Sell |
67,910
-29,240
| -30% | -$4.77M | 0.38% | 50 |
|
|
2025
Q1 | $16.6M | Sell |
97,150
-5,751
| -6% | -$963K | 0.63% | 38 |
|
|
2024
Q4 | $17.3M | Buy |
102,901
+54,699
| +113% | +$9.32M | 0.69% | 36 |
|
|
2024
Q3 | $8.35M | Buy |
48,202
+6,299
| +15% | +$1.07M | 0.37% | 72 |
|
|
2024
Q2 | $6.91M | Sell |
41,903
-2,197
| -5% | -$359K | 0.32% | 77 |
|
|
2024
Q1 | $7.16M | Sell |
44,100
-14,602
| -25% | -$2.29M | 0.34% | 74 |
|
|
2023
Q4 | $8.6M | Buy |
58,702
+1,658
| +3% | +$246K | 0.46% | 61 |
|
|
2023
Q3 | $8.32M | Sell |
57,044
-18,906
| -25% | -$2.89M | 0.46% | 59 |
|
|
2023
Q2 | $11.5M | Buy |
75,950
+3,036
| +4% | +$458K | 0.6% | 47 |
|
|
2023
Q1 | $10.9M | Buy |
72,914
+39,171
| +116% | +$5.6M | 0.58% | 39 |
|
|
2022
Q4 | $5.11M | Buy |
33,743
+1,320
| +4% | +$185K | 0.31% | 77 |
|
|
2022
Q3 | $4.09M | Buy |
32,423
+20,390
| +169% | +$2.9M | 0.28% | 95 |
|
|
2022
Q2 | $1.73M | Sell |
12,033
-793
| -6% | -$119K | 0.13% | 190 |
|
|
2022
Q1 | $1.96M | Sell |
12,826
-21,708
| -63% | -$3.4M | 0.16% | 153 |
|
|
2021
Q4 | $5.65M | Sell |
34,534
-5,611
| -14% | -$833K | 0.45% | 62 |
|
|
2021
Q3 | $5.61M | Buy |
40,145
+1,081
| +3% | +$153K | 0.46% | 60 |
|
|
2021
Q2 | $5.27M | Buy |
39,064
+1,410
| +4% | +$191K | 0.43% | 60 |
|
|
2021
Q1 | $5.1M | Buy |
37,654
+16,976
| +82% | +$2.21M | 0.46% | 57 |
|
|
2020
Q4 | $2.88M | Buy |
20,678
+1,881
| +10% | +$263K | 0.28% | 104 |
|
|
2020
Q3 | $2.61M | Buy |
18,797
+3,466
| +23% | +$460K | 0.28% | 103 |
|
|
2020
Q2 | $1.83M | Buy |
15,331
+2,021
| +15% | +$236K | 0.24% | 116 |
|
|
2020
Q1 | $1.46M | Buy |
13,310
+2,872
| +28% | +$345K | 0.24% | 95 |
|
|
2019
Q4 | $1.3M | Buy |
10,438
+295
| +3% | +$36.1K | 0.23% | 91 |
|
|
2019
Q3 | $1.26M | Buy |
10,143
+52
| +0.5% | +$6.14K | 0.2% | 107 |
|
|
2019
Q2 | $1.11M | Buy |
10,091
+7
| +0.1% | +$746 | 0.18% | 122 |
|
|
2019
Q1 | $1.05M | Buy |
10,084
+1,339
| +15% | +$130K | 0.19% | 127 |
|
|
2018
Q4 | $804K | Buy |
8,745
+8,593
| +5,653% | +$768K | 0.17% | 106 |
|
|
2018
Q3 | $13K | Sell |
152
-109
| -42% | -$8.91K | ﹤0.01% | 244 |
|
|
2018
Q2 | $20K | Buy |
+261
| New | +$19.6K | 0.01% | 192 |
|
Other funds holding PG
HCM
FWIA
CRM
CNB
II
CX Institutional's PG Position: Q2 2026 in Review
CX Institutional reduced its Procter & Gamble (PG) stake by 10% in Q2 2026, selling an estimated $973K and leaving 59,588 shares worth $8.74M. The position accounts for 0.25% of the portfolio, ranked #92.
CX Institutional first reported a position in PG in Q2 2018 and has held it in 33 quarters since. The position peaked at $17.3M in Q4 2024. 978 funds tracked by Wall St. Rank hold PG as of Q2 2026.
- CX Institutional held 59,588 shares of Procter & Gamble worth $8.74M as of Q2 2026.
- CX Institutional sold 6,686 Procter & Gamble shares in Q2 2026, an estimated $973K.
- Procter & Gamble made up 0.25% of CX Institutional's portfolio in Q2 2026, its #92 holding.
- CX Institutional first reported a position in Procter & Gamble in Q2 2018 and has held it in 33 quarters since.
- CX Institutional's Procter & Gamble position peaked at $17.3M in Q4 2024.
- 978 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.